DIMS Lenses May Slow Myopia Progression

A nearly decade-long observational follow-up found continued slowing of axial elongation into late adolescence, while refractive outcomes remained less consistent.

By
Andrea Surnit
July 8, 2026
4 min

MDSpire News

At a Glance

Category	Detail
Condition	Myopia
Key Mechanisms	DIMS lenses slow axial elongation of the eye.
Target Population	Pediatric patients aged 8 to 13 years at baseline.
Care Setting	Observational posttrial follow-up study.

Key Highlights

DIMS lenses associated with 65% reduction in axial elongation over nearly 10 years.
Cumulative axial elongation predicted at 0.44 mm for DIMS wearers vs. 1.27 mm for single-vision wearers.
Less definitive findings for refractive error progression.
Greatest treatment effect observed in younger patients, particularly before age 18.
Study highlights need for further research with appropriate control groups.

Guideline-Based Recommendations

Diagnosis

Monitor axial length and refractive error in pediatric myopia patients.

Management

Consider DIMS lenses for slowing axial elongation in myopic children.

Monitoring & Follow-up

Long-term follow-up required to assess sustained effects on eye growth.

Risks

Potential survivor bias due to attrition over the study period.

Patient & Prescribing Data

Pediatric patients previously exposed to DIMS lenses.

DIMS lenses may provide durable control of axial elongation.

Clinical Best Practices

Utilize longitudinal analysis for assessing treatment effects in myopia management.
Incorporate normative data for contextual benchmarking in myopia studies.
Acknowledge limitations of observational studies when interpreting results.